000			01975 a2200541 4500
005			20250516151948.0
264		0	_c20140401
008			201404s 0 0 eng d
022			_a1538-8514
024	7		_a10.1158/1535-7163.MCT-12-1057 _2doi
040			_aNLM _beng _cNLM
100	1		_aZhou, Binhua
245	0	0	_aDeubiquitinase inhibition of 19S regulatory particles by 4-arylidene curcumin analog AC17 causes NF-κB inhibition and p53 reactivation in human lung cancer cells. _h[electronic resource]
260			_bMolecular cancer therapeutics _cAug 2013
300			_a1381-92 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCurcumin _xanalogs & derivatives
650	0	4	_aDisease Models, Animal
650	0	4	_aEnzyme Activation _xdrug effects
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aNF-kappa B _xantagonists & inhibitors
650	0	4	_aProteasome Endopeptidase Complex _xmetabolism
650	0	4	_aProteasome Inhibitors _xpharmacology
650	0	4	_aProteolysis _xdrug effects
650	0	4	_aTumor Burden _xdrug effects
650	0	4	_aTumor Suppressor Protein p53 _xagonists
650	0	4	_aUbiquitin-Specific Proteases _xantagonists & inhibitors
650	0	4	_aUbiquitination _xdrug effects
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aZuo, Yinglin
700	1		_aLi, Baojian
700	1		_aWang, Hao
700	1		_aLiu, Hao
700	1		_aWang, Xianfeng
700	1		_aQiu, Xu
700	1		_aHu, Yun
700	1		_aWen, Shijun
700	1		_aDu, Jun
700	1		_aBu, Xianzhang
773	0		_tMolecular cancer therapeutics _gvol. 12 _gno. 8 _gp. 1381-92
856	4	0	_uhttps://doi.org/10.1158/1535-7163.MCT-12-1057 _zAvailable from publisher's website
999			_c22771103 _d22771103